Apellis Pharmaceuticals Announces Pricing of Offering of Common Stock
April 18, 2018
CRESTWOOD, Ky. and WALTHAM, Mass., – Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease